The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
Shakur Haleema, Peter Andrews, Asser Toomas, Balica Laura, Boeriu Cristian, Quintero Juan, Dewan Yashbir, Druwé Patrick, Fletcher Olivia, Frost Chris, Hartzenberg Bennie, Mantilla Jorge, Murillo-Cabezas Francisco, Pachl Jan, Ravi, Rätsep Indrek, Sampaio Cristina, Singh Manmohan, Svoboda Petr, Roberts Ian